Why Wolfe Research Remains Bullish on Eli Lilly and Company (LLY) and Its Obesity Pipeline

TheFly reported connected May 21 that Wolfe Research maintained an Outperform standing connected LLY and kept its $1,350 terms people unchanged. The steadfast highlighted late-stage Phase 3 information for retatrutide, showing beardown value simplification outcomes, reaching up to 26.1% astatine 80 weeks and exceeding 30% successful longer follow-up among higher-body-mass participants. The results besides showed meaningful improvements crossed cardinal cardiometabolic wellness indicators. Wolfe Research said these findings reenforce LLY’s enactment presumption successful GLP-1-based obesity treatments and fortify its differentiation successful the competitory metabolic illness space. The steadfast further noted that the cause campaigner whitethorn assistance acceptable a caller modular for aboriginal obesity therapies aimed astatine higher efficacy benchmarks.

Separately, connected May 20, Engage Biologics confirmed that Eli Lilly and Company (NYSE:LLY) had acquired it successful a transaction valued astatine up to $202 cardinal successful cash. The woody includes an upfront outgo on with further milestone-based payments tied to aboriginal improvement achievements. Engage Biologics is moving connected the Tethosome platform, a non-viral DNA transportation exertion designed to code challenges successful cistron transportation specified arsenic constricted potency, reduced tolerability, and restrictions connected repetition dosing.

The acquisition is intended to enactment the advancement of this level by integrating it into Lilly’s broader probe and improvement efforts successful familial medicine and precocious therapeutic transportation systems.

Eli Lilly and Company (NYSE:LLY) is simply a U.S.-based pharmaceutical steadfast that develops and manufactures medicine medicines successful areas similar cardiometabolic diseases, oncology, immunology, and neuroscience.

While we admit the imaginable of LLY arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.